Powell's Senate testimony, FTC ruling on drug prices: Catalysts

In this article:

Federal Reserve Chair Jerome Powell begins two days of testimonies before the US Senate on the current state of the economy, which investors will be listening to for cues on when the Fed could cut interest rates. On today's episode of Catalysts, Seana Smith and Madison Mills report on Powell's testimony as the market awaits key inflation data out this week.

Jim Townsend, former Deputy Assistant Secretary of Defense for European and NATO policy, joins the program to talk on the significance of President Biden hosting the NATO summit this week and what a second term of Trump leadership could mean for Ukraine in its war effort against Russia.

BlueBay senior emerging markets (EM) sovereign strategist Timothy Ash divulges the emerging markets he is seeing new investment opportunities, such as Argentina and Egypt.

Other top trending tickers on the Yahoo Finance platform include Chewy (CHWY), Helen of Troy Limited (HELE), and pharmacy benefit managers (PBMs) like CVS Caremark (CVS), Cigna Group (CI), and UnitedHealth Group (UNH) as Federal Trade Commission (FTC) officials rule on these benefit managers' ability to control drug price.

This post was written by Luke Carberry Mogan.

Advertisement